Learn About Acute Interstitial Pneumonia

What is the definition of Acute Interstitial Pneumonia?
Acute interstitial pneumonia (AIP) is a rare and serious condition that affects the lungs. The signs and symptoms generally develop and progress rapidly. In the early stages of the condition, affected people may experience upper respiratory and/or viral-like symptoms such as cough, shortness of breath, and fever. This is followed by the rapid onset of respiratory failure and the need for mechanical ventilation in the majority of cases. The underlying cause of AIP is unknown. Most cases occur sporadically in people with no family history of the condition.
Save information for later
Sign Up
What are the alternative names for Acute Interstitial Pneumonia?
  • Acute interstitial pneumonia
  • Acute interstitial pneumonitis
  • Hamman-Rich syndrome
Who are the top Acute Interstitial Pneumonia Local Doctors?
IN
Dr. Imre Noth
Pulmonary Medicine | Intensive Care Medicine
Elite
Highly rated in
9
conditions
Pulmonary Medicine
Intensive Care Medicine

UVA Health System

Pulmonary Clinic

1221 Lee St, 
Charlottesville, VA 

Imre Noth is a Pulmonary Medicine specialist and an Intensive Care Medicine expert in Charlottesville, Virginia. Noth has been practicing medicine for over 31 years and is rated as an Elite expert by MediFind in the treatment of Acute Interstitial Pneumonia. He is also highly rated in 9 other conditions, according to our data. His top areas of expertise are Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant. Noth is currently accepting new patients.

HC
Dr. Harold R. Collard
Pulmonary Medicine | Intensive Care Medicine
Elite
Highly rated in
11
conditions
Pulmonary Medicine
Intensive Care Medicine

University of California San Francisco Health System

Pulmonary Practice At Parnassus

400 Parnassus Ave, 
San Francisco, CA 

Harold Collard is a Pulmonary Medicine specialist and an Intensive Care Medicine expert in San Francisco, California. Collard has been practicing medicine for over 26 years and is rated as an Elite expert by MediFind in the treatment of Acute Interstitial Pneumonia. He is also highly rated in 11 other conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, and Lung Transplant.

 
 
 
 
Learn about our expert tiers
Learn more
PW
Dr. Paul J. Wolters
Pulmonary Medicine | Intensive Care Medicine
Elite
Highly rated in
12
conditions
Pulmonary Medicine
Intensive Care Medicine

University of California San Francisco Health System

ILD Program

400 Parnassus Ave, 
San Francisco, CA 

Paul Wolters is a Pulmonary Medicine specialist and an Intensive Care Medicine expert in San Francisco, California. Wolters has been practicing medicine for over 31 years and is rated as an Elite expert by MediFind in the treatment of Acute Interstitial Pneumonia. He is also highly rated in 12 other conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Pulmonary Fibrosis, and Lung Transplant. Wolters is currently accepting new patients.

View All Doctors
What are the latest Acute Interstitial Pneumonia Clinical Trials?
A Multi-center, Non-randomized, Non Blinded, Non-controlled Study to Investigate the Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease Associated Pulmonary Hypertension.
Who is this study for: Patients with interstitial lung disease associated pulmonary hypertension
Enrollment Status: Active, not recruiting
Publish Date: February 15, 2023
Intervention Type: Drug
Study Drug: Riociguat
Study Phase: Phase 2

Summary: The purpose of this study is to assess multiple ascending doses of a new drug (BAY63-2521) given orally, to evaluate if it is safe and can help to improve the well-being, symptoms (e.g. disturbed breathing) and outcome of pulmonary hypertension associated with lung fibrosis. Patients living with pulmonary hypertension associated with interstitial lung disease have a risk of increased number of hos...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Single-cell Sequencing of Bronchoalveolar Lavage Fluid to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis
Enrollment Status: Recruiting
Publish Date: February 15, 2023
Intervention Type: Genetic
Study Phase: Phase 1/Phase 2

Summary: A multicenter, exploratory clinical research, to map the radiation or immune checkpoint inhibitor pneumonitis in patients with alveolar lavage single-celled map. Find out the pathogenesis and prevention strategies of radiation or immune checkpoint inhibitor pneumonitis. Specific treatment is given based on the recommendation of the treatment guidelines for radiation or immune checkpoint inhibitor ...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Acute Interstitial Pneumonia?
Minimally Invasive Resection of Benign Osseous Tumors of the Spinal Column: 10 Years' Experience and Long-Term Outcomes of a Specialized Center.
Condition: Benign Osseous Tumors of Spinal Column
Journal: Medicina (Kaunas, Lithuania)
Treatment Used: Minimally Invasive Resection
Number of Patients: 32
Published: December 23, 2022
Progressive pulmonary fibrosis (PPF).
Condition: Progressive Pulmonary Fibrosis (PPF)
Journal: Tuberkuloz ve toraks
Treatment Used: Nintedanib
Published: December 20, 2022
Tired of the same old research?
Check Latest Advances
Immunoadsorption and plasmapheresis at the ICU - A description of the frequencies and indications in a single center experience and a case report.
Condition: Granulomatosis with Polyangiitis
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Treatment Used: Immunoadsorption
Number of Patients: 72
Published: December 05, 2022
View All Latest Advances